Kiniksa Announces FDA Approval of ARCALYST ® (rilonacept) for Recurrent Pericarditis
- ARCALYST is the first and only FDA-approved therapy for recurrent pericarditis -- Commercial launch expected in April 2021 -- Kiniksa...
Year: 2021
IntelGenx to Report Fourth Quarter and Full-Year 2020 Financial Results on March 25, 2021 – Conference Call to Follow
SAINT LAURENT, Quebec, March 18, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that it will...
Idera Pharmaceuticals Announces Results From ILLUMINATE-301 Trial of Tilsotolimod + Ipilimumab in anti-PD-1 Refractory Advanced Melanoma
– Objective Response Rate Endpoint Not Met –EXTON, Pa., March 18, 2021 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA;...
ARCA biopharma Announces 2020 Financial Results and Provides Corporate Update
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. Topline data from Phase 2b clinical trial evaluating rNAPc2...
ALX Oncology Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones
BURLINGAME, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage immuno-oncology company...
Sigilon Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Business Highlights
CAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional...
Trevi Therapeutics to Report Q4 and Year End 2020 Financial Results on March 25
Conference Call and Webcast to be Held at 4:30 p.m. ETNEW HAVEN, Conn., March 18, 2021 (GLOBE NEWSWIRE) -- Trevi...
Progenity Provides Corporate Updates and Reports Fourth Quarter and Full-Year 2020 Financial Results
Reports approximately 82,000 tests in the fourth quarter of 2020 Raised $118M gross proceeds in December 2020 from a concurrent...
Ortho Clinical Diagnostics Reports Fourth Quarter and Fiscal Year 2020 Results
Fourth Quarter Revenue Growth Ahead of Company Expectations at 9.1%RARITAN, N.J., March 18, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics...
CV Sciences, Inc. Reports Fiscal Year-End 2020 Financial Results
SAN DIEGO, March 18, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”),...
Trillium Therapeutics Reports Annual Operating and Financial Results and Sets Date for R&D Day
Wide-ranging transformation program completedR&D Day scheduled for April 28, 2021, to provide data updates, and announce strategic priorities and clinical...
Salarius Pharmaceuticals Reports Business Highlights with Fourth Quarter and Full-Year 2020 Financial Results
Conference Call and Live Audio Webcast Scheduled for Today, Thursday, March 18, 2021, 4:30 p.m. ETHOUSTON, March 18, 2021 (GLOBE...
vTv Therapeutics Announces Initiation of Study Evaluating TTP399’s Potential to Reduce Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes
HIGH POINT, N.C., March 18, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the...
BioRestorative Therapies Announces Filing of 2019 Annual Report on Form 10-K
MELVILLE, N.Y., March 18, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences...
JenaValve Technology Welcomes Jane Metcalf as Vice President, Regulatory Affairs and Quality
IRVINE, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated pericardial transcatheter aortic valve...
Adverum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting...
Iba – Acquisition of Own Shares
Immediate Release – March 18th, 2021 Louvain-la-Neuve, Belgium, March 18th, 2021 - In accordance with article 8:4 of the Royal...
Segra International Announces Development and Validation of In-House Assay for Hop Latent Viroid (HLVd)
VANCOUVER, British Columbia, March 18, 2021 (GLOBE NEWSWIRE) -- Segra International Corp, a leading cannabis agriculture technology company, is pleased...
Exclusive negotiations for the acquisition of an European spinal entity
Press release Ecully, 18 March 2021 – 6 p.m. Exclusive negotiations for the acquisitionof a start-up in the field of...
Santhera’s Shareholders Approve all Board Proposals at Today’s Extraordinary General Meeting
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL...